Global Vitamin D Therapy Market - 2022-2029
Vitamin D Therapy Market is expected to grow at a CAGR of 12.2% during the forecasting period (2022-2029).
Vitamin D is a fat-soluble vitamin produced by the body in response to skin being exposed to sunlight. It also occurs naturally in a few foods such as fish, fish liver oils, egg yolks, and fortified dairy and grain products. Vitamin D is essential for supporting calcium metabolism in the body. It helps the body absorb calcium from food and supplements to support the maintenance of healthy bone cells. Vitamin D also supports muscle health, plays a role in the immune system, aids cell growth, regulates blood pressure, and supports cardiovascular health. People with less than 20 ng/mL serum vitamin D levels are at risk for vitamin D deficiency. Serum levels below 12 ng/mL indicate a vitamin D deficiency. Vitamin D deficiency can cause diabetes, cancer, rickets, osteoporosis, and kidney diseases.
The market growth is driven by growing awareness about vitamin D deficiency, a rise in the geriatric population, an imbalanced diet, obesity, and a sedentary lifestyle.
Increasing vitamin D deficiencies worldwide is expected to drive market growth.
Vitamin D deficiency is linked to various chronic and infectious diseases. According to the literature, the prevalence of this deficit can vary geographically. The Middle East and North African region, which includes Saudi Arabia, has a comparatively high rate of vitamin D insufficiency, with 82% of all age groups deficient. Increased global awareness of vitamin D deficiency is a major factor influencing the market. Moreover, the National Institutes of Health (NIH) Office of Dietary Supplements (ODS) sponsored and funded a number of studies to improve scientific understanding of vitamin D's value to health.
Furthermore, increased R&D to expand the uses of vitamin D treatment is projected to help the market gain traction in the future years. The US Food and Drug Administration recently approved an increase in the amount of vitamin D that can be added as an optional ingredient to milk, as well as the addition of vitamin D to beverages made from edible plants that are intended to be milk substitutes, such as soy, almond, and coconut beverages, and edible plant-based yogurt alternatives. Thus, from the above statements, the market is expected to drive in the forecast period.
The presence and availability of global brands, as well as the challenges they encounter due to big or scant competition from local and domestic brands, are aspects the market is likely to be hampered by during the forecast period.
The vitamin D therapy market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.
Oral segment is expected to hold the largest market share in the vitamin D therapy market.
The oral segment accounted for the largest market share in 2021. The segment benefited because of the convenience of administration, increased pharmacokinetic and pharmacodynamic performance, lower toxicity risk, improved patient tolerance, and a preference for the oral route. The oral route is the most common and approved route for pharmaceutical administration. It is the simplest, most convenient, and most secure method. It is not painful, and the patient can take it as tablets or mix it with food. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.
North American region is expected to hold the largest market share in the global vitamin D therapy market.
North America accounted for the highest revenue share in 2021. Rise in cases of vitamin D deficiency and other chronic diseases such as osteoporosis, public awareness, supportive government policies, and high reimbursement. According to IOF, osteoporosis and low bone mass are significant public health threats for almost 44 million U.S. women and men aged 50 and older. Moreover, Abbot was named the leading brand in Vitamin D insufficiency treatment in 2021, with the most money invested in research and development and providing cutting-edge treatments at accessible costs. Therefore, it has increased the demand for Vitamin D therapy in the region. Thus, from the above statements, the North American region accounted for the largest market share in the forecast period.
Major key players in the vitamin D therapy market are Abbott, Sanofi, GlaxoSmithKline plc, Pfizer Inc., Merck & Co., Inc., Torrent Pharmaceuticals, Novartis International AG, Alkem Laboratories, Sun Pharmaceutical Industries, and Cadila Healthcare Ltd.
Abbott Laboratories is an American multinational medical device and healthcare company that explores, develops, manufactures, and sells a broad and diversified line of healthcare products. It split off its research-based pharmaceuticals business into AbbVie in 2013. It benefits through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Others. Its well-known products across the medical devices, diagnostics, and nutrition divisions are Pedialyte, Similac, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. One hundred nine thousand colleagues serve people in more than 160 countries.
ABOCAL: To help prevent deficiencies of Calcium, vitamin D, vitamin C and vitamin B6, for the treatment of deficiency state resulting from reduced intake of vitamin C, vitamin D and vitamin B6 in the diet.
The global vitamin D therapy market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook